Scarica l'app Stockscreener
2.51
5.64%
-0.15
Precedente Chiudi:
$2.66
Aprire:
$2.6
Volume 24 ore:
726.33K
Relative Volume:
2.05
Capitalizzazione di mercato:
$158.04M
Reddito:
$233.00K
Utile/perdita netta:
$-64.61M
Rapporto P/E:
-2.1758
EPS:
-1.1536
Flusso di cassa netto:
$-58.32M
1 W Prestazione:
+2.03%
1M Prestazione:
+20.67%
6M Prestazione:
+16.74%
1 anno Prestazione:
+118.26%
Intervallo 1D:
$2.40
$2.83
Intervallo di 1 settimana:
$2.145
$2.83
Portata 52W:
$1.105
$3.82
Connect Biopharma Holdings Ltd Stock (CNTB) Company Profile
Nome
Connect Biopharma Holdings Ltd
Settore
Industria
Telefono
858-727-1040
Indirizzo
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
Compare CNTB vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNTB
Connect Biopharma Holdings Ltd
|
2.51 | 158.04M | 233.00K | -64.61M | -58.32M | -1.1536 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Connect Biopharma Holdings Ltd Stock (CNTB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-01 | Iniziato | Lake Street | Buy |
| 2025-10-31 | Iniziato | BTIG Research | Buy |
| 2025-06-12 | Iniziato | H.C. Wainwright | Buy |
| 2024-03-04 | Iniziato | H.C. Wainwright | Buy |
| 2021-04-13 | Iniziato | Jefferies | Buy |
| 2021-04-13 | Iniziato | Piper Sandler | Overweight |
| 2021-04-13 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Connect Biopharma Holdings Ltd Borsa (CNTB) Ultime notizie
Oppenheimer Initiates Connect Biopharma(CNTB.US) With Buy Rating, Announces Target Price $8 - Moomoo
CNTB Initiates Coverage by Oppenheimer -- Rating Set to Outperfo - GuruFocus
Oppenheimer initiates Connect Biopharma stock with outperform rating By Investing.com - Investing.com Nigeria
Oppenheimer initiates Connect Biopharma stock with outperform rating - Investing.com
CNTB Stock Price, Quote & Chart - ChartMill
CNTBConnect Biopharma Holdings Ltd Dividends - Finviz
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - MPNnow.com
Form 4 Connect Biopharma Holdings Ltd For: 1 July By Investing.com - Investing.com Canada
Connect Biopharma (CNTB) director granted 3,738 fully vested shares as fees - Stock Titan
Connect Biopharma (NASDAQ: CNTB) director receives 6,718-share award as 2026 board compensation - Stock Titan
CCORF Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Connect Biopharma Holdings Limited(NasdaqGM: CNTB) added to Russell Microcap Index - marketscreener.com
Piper Sandler initiates Connect Biopharma stock with overweight rating By Investing.com - Investing.com Nigeria
Piper Sandler initiates Connect Biopharma stock with overweight rating - Investing.com
Piper Sandler Initiates Connect Biopharma(CNTB.US) With Buy Rating, Announces Target Price $7 - Moomoo
Connect Biopharma Holdings Ltd. Actuals & Estimates (NASDAQ:CNTB) - TradingView
H.C. Wainwright reiterates Buy on Connect Biopharma stock at $7 - Investing.com
Connect Biopharma Holdings Ltd (CNTB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CNTB Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
H.C. Wainwright reiterates Buy on Connect Biopharma stock at $7 By Investing.com - Investing.com South Africa
Connect Biopharma Holdings Ltd - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Connect Biopharma stock rises after Phase 2 asthma study enrollment - Investing.com
Connect Biopharma Holdings Ltd (CNTB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Institutional Confidence - TradingKey
Connect Biopharma Holdings Ltd (CNTB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Connect Biopharma stock rises after Phase 2 asthma study enrollment By Investing.com - Investing.com South Africa
Connect Biopharma completes asthma trial enrollment By Investing.com - Investing.com South Africa
Connect Biopharma completes asthma trial enrollment - Investing.com
Connect Biopharma Announces Completion of Enrollment of - GlobeNewswire
Connect Biopharma touts Rademikibart's edge as SEABREEZE data looms in 2026 - MSN
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Connect Biopharma director James Huang acquires $371,610 in shares By Investing.com - Investing.com Australia
Connect Biopharma director James Huang acquires $371,610 in shares - Investing.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Director-linked fund boosts Connect Biopharma (NASDAQ: CNTB) stake - Stock Titan
[EFFECT] Connect Biopharma Holdings Ltd SEC Filing - Stock Titan
Connect Biopharma (CNTB) Gains 4.6% as Shares Test Key Resistance at $2.61Earnings Beat Stocks - newsline.com
This Avalyn Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Canaccord Genuity Initiates Connect Biopharma at Buy With $6 Price Target - Moomoo
Connect Biopharma Holdings Ltd Azioni (CNTB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Connect Biopharma Holdings Ltd Azioni (CNTB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Huang James | Director |
Mar 31 '26 |
Buy |
3.45 |
1,160,000 |
4,002,000 |
13,160,000 |
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):